Cargando...
Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
BACKGROUND: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrospective study, we aimed to assess the TBZ effectiveness and adverse events (AEs) in Huntington disease (HD), vascular chorea, tics, dystonia, tardive oromandibular (OM) dyskinesia and other tardive syn...
Guardado en:
| Publicado en: | Ther Adv Neurol Disord |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367646/ https://ncbi.nlm.nih.gov/pubmed/28382107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616677004 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|